Beyond symptom control: Is uterine artery embolization a disease-modifying strategy for Adenomyosis?
Other
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper explores whether uterine artery embolization can be considered a disease-modifying strategy for adenomyosis, going beyond mere symptom control.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- MRI of adenomyosis: changes with uterine artery embolization 2006
- Introduction: Uterine adenomyosis, another enigmatic disease of our time 2018
- Guideline No. 437: Diagnosis and Management of Adenomyosis 2023
- Uterine artery embolization versus dienogest for symptomatic adenomyosis: A randomized controlled trial of short-term efficacy 2026
References (8)
- Guideline No. 437: Diagnosis and Management of Adenomyosis via openalex
- Introduction: Uterine adenomyosis, another enigmatic disease of our time via openalex
- MRI of adenomyosis: changes with uterine artery embolization via openalex
- Uterine artery embolization versus dienogest for symptomatic adenomyosis: A randomized controlled trial of short-term efficacy via openalex
- W4322496040 via openalex
- W2134068782 via openalex
- W4400781868 via openalex
- W4410793331 via openalex
Source provenance
- europepmc
- last seen: 2026-10-19T06:17:24.038039+00:00
- openalex
- last seen: 2026-08-25T06:02:57.817192+00:00
- pubmed
- last seen: 2026-10-19T06:11:07.932051+00:00
- unpaywall
- last seen: 2026-10-18T06:28:46.490043+00:00
License: CC0
· commercial use OK